Xifaxan (rifaximin) - Alfa Wassermann, Bausch Health
SIMPACT: SIMBA in Irritable Bowel Syndrome (IBS) (clinicaltrials.gov) - Oct 21, 2026 - P1 | N=180 | Not yet recruiting | Sponsor: University of Calgary 
New P1 trial • Gastrointestinal Disorder
http://clinicaltrials.gov/ct2/show/NCT07882953
 
Oct 21, 2026
 
Prev Next